Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
29303614
DOI
10.33549/physiolres.933834
PII: 933834
Knihovny.cz E-zdroje
- MeSH
- glutathion metabolismus MeSH
- hormony štítné žlázy krev MeSH
- hypertyreóza metabolismus MeSH
- hypotyreóza metabolismus MeSH
- jaterní mitochondrie účinky léků metabolismus MeSH
- játra účinky léků metabolismus MeSH
- krevní glukóza metabolismus MeSH
- krysa rodu Rattus MeSH
- ledviny účinky léků metabolismus MeSH
- lipidy krev MeSH
- palmový olej farmakologie MeSH
- potkani Wistar MeSH
- potravní doplňky * MeSH
- štítná žláza metabolismus MeSH
- tělesná hmotnost účinky léků MeSH
- velikost orgánu účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- glutathion MeSH
- hormony štítné žlázy MeSH
- krevní glukóza MeSH
- lipidy MeSH
- palmový olej MeSH
Red palm oil (RPO) is a rich natural source of antioxidant vitamins, namely carotenes, tocopherols and tocotrienols. However, it contains approximately 50 % saturated fatty acids the regular consumption of which could negatively modify lipid profile. The aim of our study was to test whether 7 weeks of RPO supplementation (1 g/kg body weight/day) would affect blood glucose and lipid metabolism in adult male Wistar rats with altered thyroid status. We induced hypothyroidism and hyperthyroidism in rats by oral administration of either methimazole or mixture of thyroid hormones. Different thyroid status (EU - euthyroid, HY - hypothyroid and HT - hyperthyroid) was characterized by different serum thyroid hormones levels (total and free thyroxine and triiodothyronine), changes in the activity of a marker enzyme of thyroid status - liver mitochondrial glycerol-3-phosphate dehydrogenase, and altered absolute and relative heart weights. Fasting blood glucose levels were higher in HT rats in comparison with EU and HY rats, but the changes caused by RPO supplementation were not significant. The achievement of the HY status significantly increased serum levels of total cholesterol, as well as with high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol: 2.43+/-0.15, 1.48+/-0.09, 0.89+/-0.08 mmol/l, compared to EU: 1.14+/-0.06, 0.77+/-0.06, 0.34+/-0.05 mmol/l and HT: 1.01+/-0.06, 0.69+/-0.04, 0.20+/-0.03 mmol/l, respectively. RPO supplementation did not increase significantly levels of blood lipids but tended to increase glutathione levels in the liver. In conclusion, RPO supplementation did not induce the presumed deterioration of glucose and lipid metabolism in rats with three well-characterized alterations in thyroid status.
Citace poskytuje Crossref.org